Spero Therapeutics, Inc. (SPRO) — Analyst estimates
Consensus analyst estimates for Spero Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 336.72K | -0.14 | 1 |
| 2027 | 3.20M | 0.67 | 1 |
| 2028 | 33.10M | -0.12 | 1 |
| 2029 | 99.10M | 0.75 | 1 |
Consensus analyst estimates by fiscal year.